Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Frequency Therapeutics Inc
(NQ:
FREQ
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Nov 3, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Frequency Therapeutics Inc
< Previous
1
2
3
4
5
6
Next >
Why Did Bullfrog AI Stock Jump More Than 50%?
April 05, 2023
Trading volume and share price for BFRG took significant leaps forward on news the digital biopharmaceutical company will partner with Johns Hopkins University.
Via
MarketBeat
Topics
Artificial Intelligence
Initial Public Offering
Exposures
Artificial Intelligence
Securities Market
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 21, 2023
Via
Benzinga
Frequency Therapeutics Provides Business Updates and Fourth Quarter and Full Year 2022 Financial Results
March 10, 2023
From
Frequency Therapeutics, Inc.
Via
Business Wire
Frequency Therapeutics to Participate at Upcoming March Investor Conferences
February 27, 2023
From
Frequency Therapeutics, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Thursday
February 16, 2023
OnThursday, 28 stocks made new 52-week lows.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 15, 2023
February 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 14, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2023
February 14, 2023
Via
Benzinga
Dow Gains Over 300 Points; S&P 500 Up 1%
February 13, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 300 points on Monday. The Dow traded up 1.01% to 34,211.29 while the NASDAQ rose 1.52% to 11,896.33. The S&P 500...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
February 13, 2023
Via
Benzinga
Why Frequency Therapeutics Are Trading Lower By 82%? Here Are Other Stocks Moving In Monday's Mid-Day Session
February 13, 2023
Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 120.5% to $1.02 after jumping over 72% on Friday.
Via
Benzinga
Nasdaq Rises 1.5%; G1 Therapeutics Shares Plummet
February 13, 2023
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1.5% on Monday. The Dow traded up 0.96% to 34,193.83 while the NASDAQ rose 1.52% to 11,896.75. The S&P 500...
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
February 13, 2023
On Monday, 42 companies hit new 52-week lows.
Via
Benzinga
Frequency Therapeutics' Lead Hearing Loss Program Flunks, Shifts Focus To Multiple Sclerosis, Shares Plunge
February 13, 2023
Via
Benzinga
US Stocks Open Higher; Dow Jumps 200 Points
February 13, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining around 200 points on Monday. Following the market opening Monday, the Dow traded up 0.59% to 34,069.23 while the NASDAQ rose 0.65% to...
Via
Benzinga
Frequency Therapeutics Announces Topline Results for its Phase 2b Study of FX-322 for the Treatment of Sensorineural Hearing Loss
February 13, 2023
From
Frequency Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 25, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 10, 2023
Via
Benzinga
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 10, 2023
Gainers
Via
Benzinga
Frequency Therapeutics Announces Formation of Clinical Advisory Board for Remyelination in Multiple Sclerosis Program
December 19, 2022
From
Frequency Therapeutics
Via
Business Wire
Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session
December 30, 2022
Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the...
Via
Benzinga
Frequency Therapeutics Announces First Patient Dosed in Phase 1b Study of FX-345, the Company’s Second Therapeutic Candidate for Sensorineural Hearing Loss
December 15, 2022
From
Frequency Therapeutics, Inc.
Via
Business Wire
Frequency Therapeutics to Host Virtual Investor Event, Highlighting Hearing Restoration Candidate FX-322 in Advance of Q1 Clinical Results
November 17, 2022
From
Frequency Therapeutics, Inc.
Via
Business Wire
Frequency Therapeutics Provides Business Updates and Third Quarter 2022 Financial Results
November 08, 2022
From
Frequency Therapeutics, Inc.
Via
Business Wire
Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday
November 03, 2022
Gainers Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after reporting Q3 results.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022
November 02, 2022
Upgrades
Via
Benzinga
Frequency Therapeutics Completes Enrollment of Phase 2b Study of FX-322 for the Treatment of Sensorineural Hearing Loss
October 12, 2022
From
Frequency Therapeutics, Inc.
Via
Business Wire
Frequency Therapeutics to Participate in September Investor and Medical Conferences
August 30, 2022
From
Frequency Therapeutics, Inc.
Via
Business Wire
Frequency Therapeutics Provides Business Updates and Second Quarter 2022 Financial Results
August 09, 2022
From
Frequency Therapeutics, Inc.
Via
Business Wire
Tesla, Twitter And 76 Biggest Movers From Friday
July 11, 2022
Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.